Feasibility Study to Assess the Safety and Functionality of the GluSense Continuous Glucose Monitor in Diabetic Patients

Exclusion Criteria

• •Clinical significant illness that can compromise patient's health during study such as:
• •* Significant current heart disease
• •* Significant Liver or kidney disease
• •* HIV infection
• •* Hepatitis B or Hepatitis C infection
• •* Malignancy
• •* Major allergic skin disease including plaster allergies
• •* Significant allergic disorders
• •Current or recent significant skin conditions (e.g. eczema, psoriasis,).
• •Presence of skin markings/ abnormalities around implantation site that will interfere with the skin assessment e.g. tattoos, piercings, birthmark, sunburn
• •Current alcohol or substance use judged by the IP to potentially interfere with patient study compliance.
• •Routine administration of Steroid based medications.
• •Patients currently taking part in any other clinical trial using an investigational product within the last 3 months